Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
28.9M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
33.9K
-
Shares change
-
-202K
-
Total reported value, excl. options
-
$74.6K
-
Value change
-
-$271K
-
Number of buys
-
1
-
Number of sells
-
-7
-
Price
-
$2.20
Significant Holders of MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) as of Q1 2024
9 filings reported holding MAIA - MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9K shares
of 28.9M outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (23.7K shares), MORGAN STANLEY (10.1K shares), JPMORGAN CHASE & CO (38 shares), MATHER GROUP, LLC. (24 shares), Brookstone Capital Management (0 shares), UBS Group AG (0 shares), XTX Topco Ltd (0 shares), SABBY MANAGEMENT, LLC (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), and VANGUARD GROUP INC (282K shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.